K-C Suspension Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with K-C Suspension
S
- S-T Forte (guaifenesin / hydrocodone / pheniramine / phenylephrine / phenylpropanolamine)
- S-T Forte 2 (chlorpheniramine / hydrocodone)
- Sal-Tropine (atropine)
- Sandimmune (cyclosporine)
- sarecycline
- Se-Donna PB HYOS (atropine / hyoscyamine / phenobarbital / scopolamine)
- Sectral (acebutolol)
- Servira (atropine / hyoscyamine / phenobarbital / scopolamine)
- Seysara (sarecycline)
- Simcor (niacin / simvastatin)
- Simuc-HD (guaifenesin / hydrocodone / phenylephrine)
- simvastatin
- simvastatin / sitagliptin
- Skelid (tiludronate)
- sodium polystyrene sulfonate
- Solodyn (minocycline)
- Soma Compound with Codeine (aspirin / carisoprodol / codeine)
- Sorine (sotalol)
- sotalol
- Sotalol Hydrochloride AF (sotalol)
- Sotylize (sotalol)
- Sovuna (hydroxychloroquine)
- Spantuss HD (guaifenesin / hydrocodone / pseudoephedrine)
- sparfloxacin
- Spasmolin (atropine / hyoscyamine / phenobarbital / scopolamine)
- Spasquid (atropine / hyoscyamine / phenobarbital / scopolamine)
- SRC Expectorant (guaifenesin / hydrocodone / pseudoephedrine)
- Stadol (butorphanol)
- Stagesic (acetaminophen / hydrocodone)
- Stahist (atropine / chlorpheniramine / hyoscyamine / pseudoephedrine / scopolamine)
- Statex (morphine)
- Statuss (codeine / guaifenesin / phenylpropanolamine)
- Statuss Green (chlorcyclizine / codeine / pseudoephedrine)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Su-Tuss HD Elixir (guaifenesin / hydrocodone / pseudoephedrine)
- Sumycin (tetracycline)
- Sumycin 250 (tetracycline)
- Suttar SF (codeine / guaifenesin / pseudoephedrine)
- Suttar-2 (codeine / guaifenesin / pseudoephedrine)
- SymTan (hydrocodone / pseudoephedrine)
- SymTan A (brompheniramine / hydrocodone / pseudoephedrine)
- Synalgos-DC (aspirin / caffeine / dihydrocodeine)
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.